Sequenom Inc. (SQNM) Shares Fall 5% on U.S. District Court Ruling
Tweet Send to a FriendGet Alerts SQNM Hot Sheet
Up)
Trade SQNM Now!
Shares of Sequenom Inc. (Nasdaq: SQNM) are trading down 5% on news a U.S. district court has denied the company's request for a preliminary injunction against Ariosa Diagnostics.
Sequenom is trying to prevent Ariosa from selling prenatal tests that can detect abnormalities in chromosomes. Back in February, SQNM filed a patent infringement suit against Ariosa.
Currently, Sequenom has it's own test it sells, MaterniT21 - which is made to detect certain chromosomal abnormalities, including Down Syndrome.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Sequenom is trying to prevent Ariosa from selling prenatal tests that can detect abnormalities in chromosomes. Back in February, SQNM filed a patent infringement suit against Ariosa.
Currently, Sequenom has it's own test it sells, MaterniT21 - which is made to detect certain chromosomal abnormalities, including Down Syndrome.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- Canadian Solar (CSIQ) Continues Higher Following Arbitration Win Over LDK (LDK)
- OSI Systems (OSIS) Continues Lower
- Yahoo! (YHOO) Board Said to Approve $1.1B Tumblr Deal
Create E-mail Alert Related Categories
Corporate News, Litigation, Trader Talk
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
